StocksFin Logo
ABVC logo
$ABVC

ABVC BioPharma, Inc.

ABVC country of incorporation
|
https://www.abvcpharma.com
|
Mr. Eugene Jiang
|
28 employees
NASDAQ | Healthcare | Biotechnology
ABVC reported its Q322 earnings on November 14, 2022 (89 weeks ago).
$42.27k -57.3% vs. Q321 Revenues Q322
74.59% -25.1% vs. Q321 Gross Profit Margin
-1000% ! 0% vs. Q321 Net Profit Margin
-398.46k ! 85.3% vs. Q321 Free Cash Flow Q322
$-0.12 ! -71.4% vs. Q321 EPS Q322
Company Card Q322
As reported on November 14, 2022
Is profitable?
Has Revenue Growth?
Has Net Profit Growth?
Has FCF Growth?
Has OCF Growth?
Has EPS Growth?
Pays a Dividend?
Rating
B-
Growth calculated YoY
Company Card Q322
As reported on November 14, 2022
Is profitable?
Has Revenue Growth?
Has Net Profit Growth?
Has FCF Growth?
Has OCF Growth?
Has EPS Growth?
Pays a Dividend?
Rating
B-
Growth calculated YoY
Income Statement
Full Income Statement
Period Net Revenue Cost of Revenue Net Profit EPS
FY2022 Not reported yet.
Q32022
42.27k
-86.5%
10.74k
-3.78M
-103.1%
$-0.12
Q22022
312.86k
+1119.3%
8.37k
-1.86M
+69%
$-0.06
Q12022
25.66k
1.9k
-6M
$-0.2
FY2021
355.8k
 5.09k
-12.84M
$-0.51
Q42021
-37.79k
-138.2%
2.8k
-7.93M
-339.1%
$-0.45
Q32021
99k
+214.9%
393
-1.81M
+8.4%
$-0.07
Q22021
31.44k
-88.1%
646
-1.97M
-74.7%
$-0.08
Q12021
263.15k
1.25k
-1.13M
$-0.05
FY2020
483.05k
 18.72k
-9.79M
$-0.5
FY2019
701.72k
 20.14k
-3.64M
$-0.21
FY2018
0
 0
-4.1M
$-0.36
Balance Sheet
Full Balance Sheet
Period Total Assets Total Liabilities Cash & Eq. Debt Stock Equity
FY2022 Not reported yet.
Q32022
10.48M
 4.79M
1.32M
3.11M
5.92M
Q22022
13.78M
 4.6M
2.91M
2.87M
9.33M
Q12022
12.07M
 4.71M
2.72M
3.17M
7.43M
FY2021
13.7M
 4.83M
5.83M
5.47M
8.84M
FY2020
11.61M
 8.94M
4.27M
8.88M
3.44M
FY2019
6.93M
 7.05M
144.3k
8.92M
-150.96k
FY2018
96.27k
 5.85M
40.04k
1.35M
-5.75M
Cash Flow Statement
Full Cash Flow Statement
Period Operating CF Investing CF Financing CF Capex Free Cash Flow
FY2022 Not reported yet.
Q32022
-513.7k
 -1.52M
603.5k
0
-398.46k
+88.5%
Q22022
-3.43M
 -22.03k
3.66M
-22.03k
-3.45M
-11.8%
Q12022
-2.99M
 -93.22k
0
-93.22k
-3.09M
FY2021
-7.6M
 -805.97k
10M
-17.5k
-7.62M
FY2020
-4.56M
 -225.43k
9.57M
0
-4.56M
FY2019
-3.13M
 -35.3k
3.09M
0
-3.13M
FY2018
-630.2k
 0
593k
0
-630.2k
Institutional Ownership
Dividend History
No dividend history.
Number of Employees